Monthly Archives: February 2015

Biothera Immunotherapy Binds to Multiple Immune Cell Receptors to Kill Cancer

Researchers to Present New Data at Keystone Symposia on Tumor Immunology EAGAN, MN, February 10, 2015 — Biothera’s late stage cancer immunotherapy drug binds to multiple innate immune cell receptors to exert enhanced cytotoxicity against tumor cells. Researchers will present new data showing Imprime PGG® binds to Fc gamma receptors (FcγR) in addition to complement receptor 3 (CR3) on human neutrophils and monocytes at a...

Read More